Navigation Links
VisionCare's Macular Degeneration Telescope Implant Named 'Best of What's New' 2010 by Popular Science
Date:11/17/2010

s Vision

The telescope implant is designed to improve visual acuity. The magnification provided by the implant reduces the impact of the blind spot caused by end-stage AMD. End-stage AMD causes severe to profound central vision loss in both eyes due to either wet AMD that has progressed to scarring of the macula despite drug treatments, or dry AMD that has progressed to geographic atrophy, the most advanced form of dry AMD.

"This micro-optical telescope is a medical marvel not only because it is a tiny Galilean telescope we can implant inside the eye, but because it can help our most severely visually impaired AMD patients gain meaningful vision," said Kathryn A. Colby, M.D., Ph.D., ophthalmic surgeon at Massachusetts Eye and Ear Infirmary in Boston and an Assistant Professor of Ophthalmology at Harvard Medical School.

"We finally have a technology available to provide a new treatment option for AMD patients who have progressed to end-stage disease," said Julia A. Haller, M.D., Ophthalmologist-in-Chief of the Wills Eye Institute, and Professor and Chair of the Department of Ophthalmology at Jefferson Medical College, Philadelphia, PA. "The telescope implant can help patients regain independence we take for granted and to go about social activities that keep us engaged with friends and the community."

Upon receiving the telescope in 2003 during the clinical investigations, Marian Orr's vision and lifestyle dramatically improved. Previously, the now 80 year old resident of Charlotte, NC, had to retire from her position as a law office bookkeeper because she lost her straight-ahead vision as a result of AMD. Now, she is able to read, watch TV and live alone. She says, "My dad and his brother were blind in their later years and I didn't want to be like that. The telescope implant has changed my life."

Results from the two U.S. clinical trials, conducted at 28 leading ophthalmic centers and published in peer-reviewed scientific jour
'/>"/>

SOURCE VisionCare Ophthalmic Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Ophthotech Enrolls Its First Patient in a Randomized, Controlled Phase II Study of E10030 in Macular Degeneration
2. Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of Iluvien(R) in Patients With Diabetic Macular Edema
3. ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD)
4. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
5. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
6. Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
7. Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)
8. ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
9. TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration
10. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
11. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 Research explores data ... research also   to   be presented ... ), the global specialty biopharmaceutical company, announces that it ... the American Psychiatric Association (APA) 166th Annual Meeting in ... data being presented represent Shire,s ongoing commitment to the ...
(Date:5/17/2013)... MIAMI LAKES, Fla. , May 17, 2013 ... products and delivery technology company that is developing new, patent-pending ... and minerals, announced today that it will hold a business ... on Wednesday, May 22 nd , 2013 at 4:30 PM ... Brian Tuffin will host the call and will ...
(Date:5/17/2013)... , May 17, 2013 ... developer of oral drug delivery systems, announced today that ... cleared the Company,s Investigational New Drug application(IND) for ORMD-0801, ... pleased to have the FDA clearance to proceed," stated ... "The upcoming trial is a major milestone for Oramed ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... Aug. 19 Perrigo Company (Nasdaq: PRGO;TASE) announced its ... for its Abbreviated New Drug Application (ANDA) for clobetasol ... owner. On August 17, 2010, Galderma filed ... Court for the Northern District of Texas to prevent ...
... 19 Reportlinker.com announces that a new market ... Strategic Analysis of End-user Preferences in ... http://www.reportlinker.com/p0258289/Strategic-Analysis-of-End-user-Preferences-in-the-US-Stem-Cell-Research-Tools-Markets.html The ... brand perceptions of tools and technologies currently at ...
Cached Medicine Technology:Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 2Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets 3
(Date:5/19/2013)... May 19, 2013 Passages Malibu, the ... center, has announced this week the launch of a ... brands’ social media channels. “We are always looking ... community and to get feedback regarding sobriety, what’s working ... and co-founder of the Passages Addiction Treatment Centers ...
(Date:5/19/2013)... The AMTC team will be screening local ... Convention & Trade Center on June 1st. Professionals and amateurs, ... are free of charge. , Actors, Models and Talent for ... successful artists and grads like Caitlin Kinney - SYTYCD, ... Chris Young - on his Liquid Neon 2013 Tour, Taylor ...
(Date:5/19/2013)... 2013 The legal team at Pulaski ... a concerted effort to connect women and families coping ... drugs Yaz, Yasmin & Ocella with the legal representation ... on the notorious birth control drugs as well as ... , Yaz, Yasmin & Ocella were very popular birth ...
(Date:5/18/2013)... In “Cooking with Spirits for the Spirit: A ... Hall Svisdahl’s new cookbook, readers are transported into the world ... the pickiest eater drool. “I dedicate this book to the ... , Found within the 364 pages of “Cooking with Spirits ... from fast and simple to gourmet. Each recipe greets the ...
(Date:5/18/2013)... 2013) Each year, the American Gastroenterological Association ... and achievements in gastroenterology through its esteemed recognition ... and talented individuals who work tirelessly to advance ... are pleased to announce the 2013 recognition award ... for their tremendous contributions to our field," said ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Janet Hall Svisdahl Announces Release of ‘Cooking with Spirits for the Spirit’ 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5
... , ... The National Institutes of Health (NIH) has awarded a “Grand ... Lencz, PhD, at The Feinstein Institute for Medical Research and Ariel Darvasi, ... the genetic basis of schizophrenia. More than two million dollars was awarded ...
... necessary, safe or effective , FRIDAY, Oct. 9 (HealthDay News) ... kids vaccinated against seasonal influenza or H1N1 swine flu this ... is fighting the flu on her own terms -- ... hands frequently, get plenty of sleep and take their "gummies," ...
... Strong Corporate Values, Employee Engagement and Contributions ... Place to Work, , OTTAWA, Oct. 9 /PRNewswire-FirstCall/ - ... radiopharmaceuticals, has been selected as one of Canada,s Top ... largest publisher of employment-related periodicals and online directories. , ...
... Oct. 9 The outcome of the current healthcare ... need to get healthier. From childhood obesity to alarming ... U.S. have been confronted with the consequences of lives ... the healthcare crisis, it,s that over-emphasizing one part of ...
... Genomma Lab Internacional,S.A.B. de C.V. ("Genomma") (BMV: LAB) announced ... Televisa, S.A.B.,(NYSE: TV ; BMV: TLEVISA CPO), which was ... cosmetics and over-the-counter pharmaceuticals,in the United States and Puerto Rico. ... operations during the first quarter of 2010. , ...
... SINGAPORE, Oct. 9 The global diagnostics industry has ... to Frost & Sullivan, the diagnostics and monitoring sectors ... Nitin Naik, Vice President of Frost & Sullivan,s Asia ... in Asia Pacific are projected to provide more growth ...
Cached Medicine News:Health News:Feinstein Investigators Receive Federal GO Grant to Study the Genetics of Schizophrenia 2Health News:'No Flu Shots for My Kids' 2Health News:'No Flu Shots for My Kids' 3Health News:'No Flu Shots for My Kids' 4Health News:MDS Nordion Selected One of Canada's Top 100 Employers for 2010 2Health News:The Holistic Health Show Offers Relief for Healthcare Crisis 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 2Health News:Singapore Witnesses Healthy Growth in Diagnostics Industry 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: